MedTrace Logo

Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.

NCT07770334 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-08-18

No results posted yet for this study

Summary

Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.

Conditions

  • Procalcitonin
  • Infection
  • Internal Medicine Patients

Interventions

OTHER

No Interventions

No intervention, retrospective observational study

Sponsors & Collaborators

  • Barzilai Medical Center

    lead OTHER

Principal Investigators

  • Daniel Leshin Carmel, MD · Barzilai Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2026-11-01
Completion
2026-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07770334 on ClinicalTrials.gov